- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
PALS1 antibody detects Protein associated with Lin seven 1, encoded by the MPP5 gene on chromosome 14q22.3. PALS1 antibody is widely used to study this scaffolding protein that organizes polarity complexes in epithelial cells. PALS1 belongs to the membrane-associated guanylate kinase (MAGUK) family and plays critical roles in apical-basal polarity, tight junction formation, and epithelial integrity. It is highly expressed in epithelial tissues such as kidney, liver, and intestine, as well as in neural tissues where polarity is fundamental to development.
Structurally, PALS1 contains PDZ, SH3, and GUK domains typical of MAGUK proteins, enabling it to form multiprotein complexes at cell-cell junctions. Its L27 domain mediates binding to PATJ, while its PDZ domain interacts with CRB3, forming the Crumbs polarity complex. Through these interactions, PALS1 anchors polarity proteins to the apical membrane and organizes tight junctions, ensuring epithelial barrier function. Alternative isoforms further diversify its regulatory roles in different tissues.
Functionally, PALS1 coordinates epithelial polarity and morphogenesis. By stabilizing the Crumbs complex, it controls apical domain identity and tight junction assembly. PALS1 also interacts with cytoskeletal regulators, influencing adhesion and vesicle trafficking. Loss of PALS1 disrupts epithelial polarity, leading to leaky barriers, impaired morphogenesis, and developmental defects. In neurons, PALS1 participates in synapse organization and neuronal migration. Researchers use PALS1 antibody to examine polarity, adhesion, and developmental signaling.
Clinically, mutations and reduced expression of PALS1 are linked to ocular and renal diseases. PALS1 deficiency is associated with retinal degeneration, congenital nephrotic syndrome, and hydrocephalus in model organisms. Aberrant expression has also been observed in cancers, where disruption of polarity complexes contributes to invasion and metastasis. As a polarity regulator, PALS1 represents a biomarker and potential therapeutic target in both epithelial and neurological disorders. NSJ Bioreagents supplies PALS1 antibody to support research in epithelial biology, cancer, and developmental disease.
Experimentally, PALS1 antibody is used in western blotting to detect the ~80 kDa protein, in immunofluorescence microscopy to visualize tight junctions, and in immunohistochemistry to assess epithelial expression. Co-immunoprecipitation with PALS1 antibody allows identification of polarity complex components and their dynamic regulation.
Optimal dilution of the PALS1 antibody should be determined by the researcher.
E.coli-derived human MPP5/PALS1 recombinant protein (Position: R86-D386) was used as the immunogen for the PALS1 antibody.
After reconstitution, the PALS1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.